CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial
Jia Liu(Garvan Institute of Medical Research), Lin Shen(Peking University), Jinbo Yue(Shandong Tumor Hospital), Aiping Zhou(National Cancer Center), Andrea Tazbirkova(Canossa Private Hospital), Zimin Liu(Qingdao University), Hui Zhou(Xiamen University), Yuping Sun(Shandong University), Juan Du(China Shenhua Energy (China)), Xiuying Xiao(Shanghai Jiao Tong University), Yingmei Guo, Jian Ruan(Zhejiang Chinese Medical University), Yang Luo(Kunming University), Weiming Yu(Ningbo University), Yanru Qin(First Affiliated Hospital of Zhengzhou University), Yueyin Pan(Anhui Provincial Hospital), Chuangxin Lu(Henan Provincial People's Hospital), Meili Sun(Jinan Central Hospital), Ping Chen(Ningxia Medical University), Zhi‐Hua Li(Sun Yat-sen University), Xianjun Yu(Fudan University Shanghai Cancer Center), Jianwei Yang(Fujian Provincial Cancer Hospital), Ting Deng(Tianjin Medical University Cancer Institute and Hospital), Xin Zhao(Capital Medical University), Xinjun Liang(Hubei Cancer Hospital), Jian Zhang(Changchun Institute of Biological Products), Jie Li(Xidian University), Suyi Li(Anhui Provincial Hospital), Xianglin Yuan(Tongji Hospital), Enxiao Li(First Affiliated Hospital of Xi'an Jiaotong University), Lili Sheng(First Affiliated Hospital of Wannan Medical College), Zhenyang Liu(Qingdao University), Jieer Ying(Zhejiang Cancer Hospital), Jifang Gong(Peking University), Rongfeng Song(Jiangxi Provincial Cancer Hospital), Michelle Frances Morris(Sunshine Coast University Hospital), Yiping Mou(Zhejiang Provincial People's Hospital), Xiujuan Qu(First Hospital of China Medical University)
Cited by 29
Related Papers
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice
|Nature Medicine|2009|775
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657